Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 7.26
(0.55%)
CNY 7.26
(0.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 173.05 Million | 244.55 Million | 188.85 Million | 151.95 Million | 201.27 Million | 147.67 Million |
| Net Income | 147.37 Million | 152.62 Million | 142.75 Million | 117.02 Million | 140.59 Million | -424.24 Million |
| Depreciation & Amortization | 49.28 Million | 51.2 Million | 52.98 Million | 42.25 Million | 41.6 Million | 39.02 Million |
| Deferred income taxes | -9 Million | -5.15 Million | - | -2.98 Million | 3.21 Million | 3.08 Million |
| Stock-based compensation | - | 17.44 Million | - | 2.98 Million | - | 520.01 Million |
| Change in working capital | -15.61 Million | 35.72 Million | -2.11 Million | -7.12 Million | 22.91 Million | 12.88 Million |
| Other non-cash items | 3.7 Million | -7.29 Million | -4.76 Million | -197.81 Thousand | -3.83 Million | 520.01 Million |
| Investing Cash Flow | -307.68 Million | -114.5 Million | -310.53 Million | -22.21 Million | -130.79 Million | -263.08 Million |
| Investments in PPE | -301.37 Million | -125.28 Million | -72.54 Million | -83.3 Million | -55.24 Million | -48.5 Million |
| Acquisitions | 32.74 Thousand | 23.84 Thousand | 41.17 Thousand | 83.34 Million | 55.24 Million | -518.84 |
| Investment purchases | -2.19 Billion | -3.22 Billion | -2.7 Billion | -1.24 Billion | -832 Million | -1.16 Billion |
| Sales/Maturities of investments | 2.18 Billion | 3.23 Billion | 2.46 Billion | 1.3 Billion | 756.44 Million | 947.9 Million |
| Other Investing Activities | -6.31 Million | 0.85 | 1.03 | -83.3 Million | -55.24 Million | 512.09 Thousand |
| Financing Cash Flow | 44.01 Million | -79.94 Million | 242 Million | -111.18 Million | -44.61 Million | 32.53 Million |
| Debt repayment | -196.48 Million | -11.77 Million | -11.09 Million | - | - | - |
| Dividends payments | -139.14 Million | -68.17 Million | - | -100 Million | -41.61 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.32 Million | -0.77 | 253.09 Million | -4.17 Million | -3 Million | 32.53 Million |
| Accounts receivables | 3.81 Million | 6.81 Million | 22.38 Million | 25.24 Million | 18.41 Million | -646.1 Thousand |
| Accounts payables | -11.54 Million | 26.11 Million | 4.59 Million | -19.6 Million | 15.13 Million | 19.67 Million |
| Inventory | 1.12 Million | 7.95 Million | -25.14 Million | -14.07 Million | -13.84 Million | -9.22 Million |
| Other working capital | -20.55 Million | -5.15 Million | -3.95 Million | 1.3 Million | 3.21 Million | 22.11 Million |
| Cash at beginning of period | 292.13 Million | 241.63 Million | 121.4 Million | 103.15 Million | 77.21 Million | 159.87 Million |
| Cash at end of period | 201.59 Million | 292.13 Million | 241.63 Million | 121.4 Million | 103.15 Million | 77.21 Million |
| Capital Expenditure | -301.37 Million | -125.28 Million | -72.54 Million | -83.3 Million | -55.24 Million | -48.5 Million |
| Effect of forex changes on cash | 79.45 Thousand | 396 Thousand | -100.3 Thousand | -303.21 Thousand | 75.87 Thousand | 221.3 Thousand |
| Net cash flow / Change in cash | -90.54 Million | 50.5 Million | 120.22 Million | 18.25 Million | 25.94 Million | -82.65 Million |
| Free Cash Flow | -128.32 Million | 119.27 Million | 116.31 Million | 68.64 Million | 146.03 Million | 99.17 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.5 Million | 38.24 Million | 38.39 Million | 147.37 Million | 27.13 Million | 43.6 Million |
| Depreciation & Amortization | - | 13.05 Million | 13.05 Million | 49.28 Million | 49.28 Million | -23.92 Million |
| Deferred income taxes | - | - | - | -9 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 1282.00 | - | -15.61 Million | 4.93 Million | -4.3 Million |
| Other non-cash items | 25.35 Million | 17.49 Million | -624.82 Thousand | 3.7 Million | -32.5 Million | 41.11 Million |
| Investing Cash Flow | -115.03 Million | -46.67 Million | 60.93 Million | -307.68 Million | -106.72 Million | -114.14 Million |
| Investments in PPE | -18.22 Million | -16.68 Million | -60.67 Million | -301.37 Million | -54.47 Million | -93.39 Million |
| Acquisitions | 122.17 Thousand | 14.4 Thousand | 37.84 Thousand | 32.74 Thousand | 9550.00 | 780.00 |
| Investment purchases | -584 Million | -583 Million | -382 Million | -2.19 Billion | -411 Million | -435 Million |
| Sales/Maturities of investments | 487.07 Million | 553 Million | 503.57 Million | 2.18 Billion | 358.74 Million | 414.24 Million |
| Other Investing Activities | 122.17 Thousand | -27.06 Million | 121.6 Million | -6.31 Million | -52.24 Million | 0.44 |
| Financing Cash Flow | -2.21 Million | -57.8 Million | -23.27 Million | 44.01 Million | 32 Million | 75.24 Million |
| Debt repayment | - | -23.71 Million | -21.46 Million | -196.48 Million | -34.52 Million | -77.99 Million |
| Dividends payments | - | -49.32 Million | - | -139.14 Million | -139.14 Million | - |
| Common Stock Repurchased | 51.09 Million | -51.09 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.21 Million | -10.72 Million | -44.74 Million | -13.32 Million | -2.51 Million | 153.23 Million |
| Accounts receivables | - | 799.67 Thousand | - | 3.81 Million | 3.81 Million | -4.97 Million |
| Accounts payables | - | - | - | -11.54 Million | - | - |
| Inventory | - | -798.38 Thousand | - | 1.12 Million | 1.12 Million | 669.37 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 215.26 Million | 505.25 Million | 201.59 Million | 292.13 Million | 227.52 Million | 209.97 Million |
| Cash at end of period | 155.72 Million | 394.77 Million | 277.03 Million | 201.59 Million | 201.59 Million | 227.52 Million |
| Capital Expenditure | -18.22 Million | -16.68 Million | -60.67 Million | -301.37 Million | -54.47 Million | -93.39 Million |
| Effect of forex changes on cash | -80.37 Thousand | 21.4 Thousand | 8275.64 | 79.45 Thousand | -65.33 Thousand | -30.95 Thousand |
| Net cash flow / Change in cash | -59.53 Million | -110.47 Million | 75.43 Million | -90.54 Million | -25.92 Million | 17.55 Million |
| Free Cash Flow | 42.63 Million | 26 Million | -22.9 Million | -128.32 Million | -5.61 Million | -36.9 Million |
603115
RYOOF
ASRV
603615
0J51
CLILF